Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized three-period crossover clamp trial of BC222 human insulin vs Huminsulin Normal vs Humalog in type 1 diabetes
2014-001432-11Phase 2Completed
- Sponsor
- Adocia
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Adocia. Primary endpoint: AUCIns(0-1h). Started May 2014; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-001432-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001432-11.